ESMO 2019 | Combination therapy in gynecoligcal cancer

Mansoor Raza Mirza

Mansoor Raza Mirza, MD, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, speaks on the FDA approval of lenvatonib and the future of combination immunotherapy in endometrial cancers. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video